Skip to main content

Topotecan

Hycamtin

Calculate dosage
Sourced from primary literature. Awaiting credentialed clinical reviewer — our editorial process.

Drug Class

Oncology

Routes

IVPO

Indications

LymphomaLymphoma (investigational)solid tumors (investigational)

Mechanism of Action

Semi-synthetic camptothecin analogue that inhibits topoisomerase I by stabilizing the enzyme-DNA complex, preventing DNA religation and causing lethal double-strand breaks.

Side effects & warnings

Severe myelosuppression is dose-limiting. Monitor CBC closely. Dose-reduce in renal impairment. Used investigationally for lymphoma and solid tumors in dogs.

Species with Topotecan dosing data (2 dose rules)

Evidence levels across 2 dose rules

Weak×1Anecdotal×1

Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.

Backed by a published primary source

  • · Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed

Sample dosing (2 of 2 cited rules)

Free-tier preview — dog and cat dosing. Pro and Student unlock all 2 species including reptiles, birds, pocket pets, livestock, and equine.

SpeciesRouteDoseFrequencyEvidenceSource
Dog (Domestic)IV0.75–1 mg/kgIV over 30 min q24h x 5d, q21d cyclesWeakWithrow & MacEwen's Small Animal Clinical Oncology, 6th Ed
Cat (Domestic)IV0.5–0.75 mg/kg0.5-0.75mg/m2 IV q24h x 3-5 days, q21 daysAnecdotalWithrow & MacEwen's Small Animal Clinical Oncology, 6th Ed

Upgrade for Full Details

Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.

View Plans